COMP <GO>
AVAV vs TMO // ENTERPRISE SCALE & MARKET CAP
AeroVironment Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: AVAV 2
— TMO 10
▲ ENTERPRISE SCALE & MARKET CAP LEADER: TMO
LAST: $126.11 (-6.50%) • MKT CAP: $6.85B
market-cap
$6.85B
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
market-cap
$262.22B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AVAV VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AVAV | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 25.30% | 41.00% | -15.70 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -7.60% | 9.30% | -16.90 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.06% | 2.40% | -4.46 | TMO | /fcf-yield <GO> |
| Operating Margin | -15.70% | 17.40% | -33.10 | TMO | /operating-margins <GO> |
| Net Profit Margin | -13.40% | 15.10% | -28.50 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 140.90% | 3.90% | +137.00 | AVAV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.07 | 4.50 | -2.43 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.70% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.5 | 59.1 | -15.69 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.94 | 0.94 | 0.00 | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 34.0x | 36.3x | -2.30 | AVAV | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $6.85B | $262.22B | -$255.36B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AVAV REV | TMO REV | AVAV GROSS % | TMO GROSS % | AVAV FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.98B | $44.56B | 25.3% | 44.0% | -$140.9M | $6.29B |
| FY 2024 | $820.6M | $42.88B | 38.8% | 44.0% | -$20.9M | $7.27B |
| FY 2023 | $716.7M | $42.86B | 44.0% | 44.0% | -$17.0M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AVAV // BETA 0.94
TMO // BETA 0.94